TD Cowen reiterates Buy rating on Eli Lilly, $1250 target
TD Cowen reiterated a Buy rating on Eli Lilly with a $1250 price target, implying 7.3% upside versus the Sep 21 close of $1164.89.
TD Cowen reiterated a Buy rating on Eli Lilly with a $1250 price target, implying 7.3% upside versus the Sep 21 close of $1164.89.